About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

The New Malaria Wonder Vaccine

by Medindia Content Team on October 18, 2007 at 8:15 PM
Font : A-A+

The New Malaria Wonder Vaccine

It was also found that the vaccine reduced clinical illness due to malaria by 35 pct over a half-year period.

Though a large-scale Phase III study is essential to establish the efficacy of the vaccine, the results of the new study is encouraging.

Advertisement

The main objective of the study was to evaluate whether the vaccine should be cautiously administered for the age group more susceptible to malaria.

"We have shown for the first time that a vaccine can reduce the risk of malaria infection in young African infants exposed to intense P. falciparum transmission," Lancet quoted CISM's Pedro Alonso, MD, PhD, senior author of The Lancet article, principal investigator of the study, and head of the Barcelona Center for International Health Research (CRESIB) at the Hospital Clinic of the University of Barcelona, as saying,
Advertisement

"These tantalizing and unprecedented results further strengthen the vision that a vaccine may contribute to the reduction of the intolerable burden of disease and death caused by malaria,' he added.

"We have invested over US$300 million in the development of this vaccine to make it as safe and effective as possible," said Jean Stéphenne, president of GSK Biologicals, the vaccine division of GSK.

"Our collaboration with the PATH Malaria Vaccine Initiative and CISM, which dates back to 2001, demonstrates how public-private partnerships can help overcome critical health problems in Africa. Anticipating licensure, we are already working with our partners and with international donors to ensure that this vaccine is affordable and available to all who need it," Stephenne added.

"While other Phase II studies of this vaccine candidate are underway, this study helps pave the way for a pivotal Phase III trial of what could be the first malaria vaccine for infants and young children in Africa," added Christian Loucq, MD, director of the PATH Malaria Vaccine Initiative.

"The world urgently needs a safe and effective vaccine to reduce the suffering malaria causes," Loucq said.

The RTS,S vaccine is a combination of P.falciparum circumsporozoite protein (CSP) with hepatitis B surface antigen. Fused with a proprietary GSK Adjuvant System, RTS,S triggers the production of antibodies and T cells that hamper the ability of the malaria parasite to infect humans.

If the results continue offering promising results, the trial will move on to a Phase III trial

Source: ANI
SPH /J
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
January is the Thyroid Awareness Month in 2022
Menstrual Disorders
Coffee May Help You Fight Endometrial Cancer
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Malaria-water Malaria Mosquito Diseases Fever Malaria - Protection Strategies 

Recommended Reading
Sanofi Pasteur Teams Up With Institut Pasteur To Develop Malaria Vaccine
Sanofi Pasteur, the vaccine unit of pharmaceutical company Sanofi Aventis, plans to partner with ......
Vaccine Hope for Malaria
One person dies of it every 30 seconds, it rivals HIV and tuberculosis as the world's most deadly .....
Fever
Fever or Pyrexia is an elevation in normal body temperature. Causes of fever include infections, inj...
Malaria
Malaria is caused by a parasite that enters blood through the bite of an infected mosquito. It is ch...
Malaria - Protection Strategies
Malaria is a dangerous disease with lethal consequences that requires protective measures for preven...
Mosquito Diseases
Mosquito-borne diseases, like malaria, filaria, dengue, etc are common in places conducive of mosqu...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
CONSULT A DOCTOR
I have read and I do accept terms of use - Telemedicine

Advantage Medindia: FREE subscription for 'Personalised Health & Wellness website with consultation' (Value Rs.300/-)